文献速递质量管理与危急值临床生化

试剂批号与多测量系统对质控数据变异系数估计的影响

Influence of reagent lots and multiple measuring systems on estimating the coefficient of variation from quality control data; implications for uncertainty estimation and interpretation of QC results.
PubMed 文献 · Clin Chem Lab Med · 2020-01-01

该研究按质控品批号和试剂批号对BioRad Multiqual质控数据分区,在3台Abbott Architect c8000上计算ALT、肌酐、葡萄糖、钠的CV,发现CV在不同分区和仪器间差异显著,提示估计不确定度和解读质控结果时应使用足够长时间间隔的合并CV。

要点

  • CV在不同质控品批号和试剂批号间差异可达数倍。
  • 相同规格的不同仪器间合并CV也可存在差异。
  • 用于不确定度估计和质控解读的CV应基于足够长时间间隔的合并CV。

核心结论

  • 质控数据计算的CV在不同质控品批号、试剂批号和相同规格仪器间差异较大。
  • 用于估计不确定度或解读单次质控结果的CV应来自足够长时间间隔的合并CV,以代表测量系统的典型性能。
  • 提供给检验结果使用者的不确定度估计本身也具有不确定度,可能影响医疗决策。

研究设计与样本

  • 研究分析了BioRad Multiqual冷冻液体质控品在2年间隔内的结果,按质控品批号和试剂批号分区。
  • 在3台Abbott Architect c8000仪器上测量血清丙氨酸氨基转移酶(ALT)、肌酐(酶法)、葡萄糖和钠,计算每个分区的均值和CV。

主要发现

  • 两个质控水平的CV在不同分区和仪器间差异:ALT为5.8倍和3.3倍,肌酐为4.7倍和2.1倍,葡萄糖为2.0倍和2.6倍,钠为2.1倍和2.0倍。
  • 两个质控水平的合并CV在仪器间差异:ALT为1.78倍和1.11倍,肌酐为1.63倍和1.11倍,葡萄糖为1.08倍和1.06倍,钠为1.24倍和1.31倍。

临床怎么用

  • 应使用足够长时间间隔的合并CV来估计测量不确定度或作为解读单次质控结果的基础。
  • 需注意不同质控品批号、试剂批号和仪器间CV的差异,避免使用短期数据得出的CV代表典型性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Clinical laboratories use internal quality control (QC) data to calculate standard deviation (SD) and coefficient of variation (CV) to estimate uncertainty of results and to interpret QC results. We examined the influence of different instruments, and QC and reagent lots on the CV calculated from QC data. Methods Results for BioRad Multiqual frozen liquid QC samples over a 2-year interval were partitioned by QC and reagent lots. The mean and CV were calculated for each partition for each of three Abbott Architect c8000 instruments for measuring serum alanine amino transferase (ALT), creatinine (enzymatic), glucose and sodium. Results CVs differed among partitions and instruments for two QC levels by 5.8- and 3.3-fold for ALT, by 4.7- and 2.1-fold for creatinine, by 2.0- and 2.6-fold for glucose, and by 2.1- and 2.0-fold for sodium. Pooled CVs for two QC levels varied among instruments by 1.78- and 1.11-fold for ALT, by 1.63- and 1.11-fold for creatinine, by 1.08- and 1.06-fold for glucose, and by 1.24- and 1.31-fold for sodium. Conclusions The CVs from QC data varied substantially among QC and reagent lots and for different identical specification instruments. The CV used to estimate uncertainty for a measurement result or as the basis for interpreting individual QC results must be derived over a sufficient time interval to obtain a pooled CV that represents "typical" performance of a measuring system. An estimate of uncertainty provided to users of laboratory results will itself have uncertainty that can influence medical decisions.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Ellis AD, Gross AR, Budd JR, et al. Influence of reagent lots and multiple measuring systems on estimating the coefficient of variation from quality control data; implications for uncertainty estimation and interpretation of QC results. Clin Chem Lab Med. 2020. PMID: 32883061. doi:10.1515/cclm-2020-0320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。